{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:30Z","timestamp":1792790550245,"version":"4.5.0"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Recurrent urinary tract infections (rUTI) represent a major healthcare and economic burden along with a significant impact on patient\u2019s morbidity and quality of life, even in the absence of well-known risk factors, such as vesicoureteral reflux. Despite numerous attempts to find a suitable therapeutic option, there is no clear benefit of any currently available intervention for prevention of UTI recurrence and its long-term consequences such as hypertension, renal scarring and\/or insufficiency. The common treatment practice in many centers around the globe involves the use of continuous low-dose antibiotic prophylaxis, irrespective of various studies indicating increased microbial resistance against the prophylactic drug, leading to prolonged duration and escalating the cost of UTI treatment. Moreover, the rapid appearance of multi-drug resistant uropathogens is threatening to transform UTI to untreatable disease, while impaired host-microbiota homeostasis induced by a long-term use of antibiotics predisposes patients for various autoimmune and infectious diseases. New biomarkers of the increased risk of UTI recurrence could therefore assist in avoiding such outcomes by revealing more specific patient population which could benefit from additional interventions. In this light, the recent findings suggesting a crucial role of urothelial innate immunity mechanisms in protection of urinary tract from invading uropathogens might offer new diagnostic, prognostic and even therapeutic opportunities. Uroepithelial cells detect uropathogens <jats:italic>via<\/jats:italic> pattern recognition receptors, resulting in activation of intracellular signaling cascade and transcription factors, which ultimately leads to an increased production and secretion of chemokines, cytokines and antimicrobial peptides into the urinary stream. Emerging evidence suggest that the disturbance of a single component of the urinary tract innate immunity system might increase susceptibility for rUTI. The aim of the current review is to update clinicians and researchers on potential biomarkers of host immune response alterations predisposing for rUTI and propose those well worth exploring further. For this purpose, over a hundred original papers were identified through an extensive PubMed and Scopus databases search. This comprehensive review might enrich the current clinical practice and fill the unmet clinical needs, but also encourage the development of therapeutic agents that would facilitate urinary bacterial clearance by enhancing the host immune response.<\/jats:p>","DOI":"10.3389\/fmed.2022.931717","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:03:32Z","timestamp":1656911012000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["A Systematic Review of the (Un)known Host Immune Response Biomarkers for Predicting Recurrence of Urinary Tract Infection"],"prefix":"10.3389","volume":"9","author":[{"given":"Iva","family":"Sori\u0107 Hosman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cvitkovi\u0107 Roi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovro","family":"Lamot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S1701-216334717-X","article-title":"SOGC urogynaecology committee, SOGC family physicians advisory committee. Recurrent urinary tract infection.","volume":"32","author":"Epp","year":"2010","journal-title":"J Obstet Gynaecol Can."},{"key":"B2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0924-857900350-2","article-title":"Recurrent urinary tract infection in women.","volume":"17","author":"Hooton","year":"2001","journal-title":"Int J Antimicrob Agents."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/s0002-934301054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.298.2.179","article-title":"Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.","volume":"298","author":"Conway","year":"2007","journal-title":"JAMA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s004670000493","article-title":"Recurrence and follow-up after urinary tract infection under the age of 1 year.","volume":"16","author":"Nuutinen","year":"2001","journal-title":"Pediatr Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.urology.2003.10.055","article-title":"Children with a febrile urinary tract infection and a negative radiologic workup: factors predictive of recurrence.","volume":"63","author":"Mingin","year":"2004","journal-title":"Urology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1542\/peds.2005-1362","article-title":"Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.","volume":"117","author":"Garin","year":"2006","journal-title":"Pediatrics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/s0022-347690045-3","article-title":"Primary and acquired renal scarring in boys and girls with urinary tract infection.","volume":"136","author":"Wennerstr\u00f6m","year":"2000","journal-title":"J Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00860724","article-title":"Urinary infection, reflux and renal scarring in females continuously followed for 13-38 years.","volume":"9","author":"Martinell","year":"1995","journal-title":"Pediatr Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF00856822","article-title":"Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood\u2013a 27-year follow-up.","volume":"6","author":"Jacobson","year":"1992","journal-title":"Pediatr Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","article-title":"Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT).","volume":"18","author":"Wagenlehner","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection.","volume":"366","author":"Hooton","year":"2012","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1442-2042.2006.01316.x","article-title":"Cystoscopy in women with recurrent urinary tract infection.","volume":"13","author":"Lawrentschuk","year":"2006","journal-title":"Int J Urol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e13977","DOI":"10.1111\/ijcp.13977","article-title":"Rationalising the use of investigation for urinary tract infections: analysis of 700 patients and proposal for a diagnostic algorithm.","volume":"75","author":"Dokubo","year":"2021","journal-title":"Int J Clin Pract."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.juro.2014.10.092","article-title":"Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux.","volume":"193","author":"De Bessa","year":"2015","journal-title":"J Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/apa.14988","article-title":"Italian Society of Pediatric Nephrology. Updated Italian recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in young children.","volume":"109","author":"Ammenti","year":"2020","journal-title":"Acta Paediatr."},{"key":"B17","year":"2007","journal-title":"Clinical Guideline. Urinary Tract Infection Under 16s: Diagnosis and Management."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20163026","DOI":"10.1542\/peds.2016-3026","article-title":"Reaffirmation of AAP clinical practice guideline: the diagnosis and management of the initial urinary tract infection in febrile infants and young children 2\u201324 months of age.","volume":"138","year":"2016","journal-title":"Pediatrics."},{"key":"B19","first-page":"671","article-title":"Recurrent lower urinary tract infections in women. American college of radiology. ACR Appropriateness Criteria.","volume":"215","author":"Segal","year":"2000","journal-title":"Radiology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5489\/cuaj.11214","article-title":"Guidelines for the diagnosis and management of recurrent urinary tract infection in women.","volume":"5","author":"Dason","year":"2011","journal-title":"Can Urol Assoc J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1542\/peds.105.4.789","article-title":"Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life.","volume":"105","author":"Schoen","year":"2000","journal-title":"Pediatrics."},{"key":"B22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/BF00853603","article-title":"Management of children with unobstructed urinary tract infection.","volume":"1","author":"Jodal","year":"1987","journal-title":"Pediatr Nephrol."},{"key":"B23","first-page":"133","article-title":"Behavioral and functional abnormalities linked with recurrent urinary tract infections in girls.","volume":"16","author":"Mazzola","year":"2003","journal-title":"J Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1542\/peds.112.5.1134","article-title":"Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life?","volume":"112","author":"Shaikh","year":"2003","journal-title":"Pediatrics."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/315827","article-title":"Risk factors for recurrent urinary tract infection in young women.","volume":"182","author":"Scholes","year":"2000","journal-title":"J Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.juro.2010.03.139","article-title":"Family history and risk of recurrent cystitis and pyelonephritis in women.","volume":"184","author":"Scholes","year":"2010","journal-title":"J Urol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.juro.2007.10.078","article-title":"Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infections.","volume":"179","author":"Minardi","year":"2008","journal-title":"J Urol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jiac.2021.06.006","article-title":"Complicated urinary tract infection in patients with benign prostatic hyperplasia.","volume":"27","author":"Choi","year":"2021","journal-title":"J Infect Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.juro.2014.08.112","article-title":"Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis.","volume":"193","author":"Wang","year":"2015","journal-title":"J Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"CD001534","DOI":"10.1002\/14651858.CD001534.pub4","article-title":"Long-term antibiotics for preventing recurrent urinary tract infection in children.","volume":"4","author":"Williams","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e20163145","DOI":"10.1542\/peds.2016-3145","article-title":"Antibiotic prophylaxis for urinary tract infection-related renal scarring: a systematic review.","volume":"139","author":"Hewitt","year":"2017","journal-title":"Pediatrics."},{"key":"B32","doi-asserted-by":"publisher","first-page":"CD001532","DOI":"10.1002\/14651858.CD001532.pub2","article-title":"Interventions for primary vesicoureteric reflux.","volume":"3","author":"Wheeler","year":"2004","journal-title":"Cochrane Database Syst Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e20180119","DOI":"10.1542\/peds.2018-0119","article-title":"Uropathogen resistance and antibiotic prophylaxis: a meta-analysis.","volume":"142","author":"Selekman","year":"2018","journal-title":"Pediatrics."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1371\/journal.pbio.0060280","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.","volume":"6","author":"Dethlefsen","year":"2008","journal-title":"PLoS Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"544460","DOI":"10.3389\/fped.2020.544460","article-title":"The dark side of antibiotics: adverse effects on the infant immune defense against infection.","volume":"8","author":"Shekhar","year":"2020","journal-title":"Front Pediatr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.chom.2015.04.006","article-title":"Antibiotics, pediatric dysbiosis, and disease.","volume":"17","author":"Vangay","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00467-019-04269-9","article-title":"Innate immunity and urinary tract infection.","volume":"35","author":"Ching","year":"2020","journal-title":"Pediatr Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response.","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1046\/j.1462-5822.2001.00101.x","article-title":"Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of toll-like receptors within the human urinary tract.","volume":"3","author":"B\u00e4ckhed","year":"2001","journal-title":"Cell Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e5990","DOI":"10.1371\/journal.pone.0005990","article-title":"Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women.","volume":"4","author":"Hawn","year":"2009","journal-title":"PLoS One."},{"key":"B42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1203\/pdr.0b013e318030d1f4","article-title":"Heat shock protein 72 (HSPA1B) gene polymorphism and toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children.","volume":"61","author":"Karoly","year":"2007","journal-title":"Pediatr Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/CS20070214","article-title":"Toll-like receptor polymorphisms and susceptibility to human disease.","volume":"114","author":"Misch","year":"2008","journal-title":"Clin Sci (Lond)."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e14223","DOI":"10.1371\/journal.pone.0014223","article-title":"Association of toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults.","volume":"5","author":"Yin","year":"2010","journal-title":"PLoS One."},{"key":"B45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1744-313X.2007.00709.x","article-title":"Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children.","volume":"34","author":"Tabel","year":"2007","journal-title":"Int J Immunogenet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense.","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors.","volume":"6","author":"Honda","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1001109","DOI":"10.1371\/journal.ppat","article-title":"Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.","volume":"6","author":"Fischer","year":"2010","journal-title":"PLoS Pathog."},{"key":"B49","doi-asserted-by":"publisher","first-page":"336ra59","DOI":"10.1126\/scitranslmed.aaf1156","article-title":"IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections.","volume":"8","author":"Puthia","year":"2016","journal-title":"Sci Transl Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1172\/JCI71630","article-title":"\u03b1-Intercalated cells defend the urinary system from bacterial infection.","volume":"124","author":"Paragas","year":"2014","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00467-017-3607-6","article-title":"Urinary NGAL deficiency in recurrent urinary tract infections.","volume":"32","author":"Forster","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00467-014-2989-y","article-title":"Pediatric reference ranges for acute kidney injury biomarkers.","volume":"30","author":"Bennett","year":"2015","journal-title":"Pediatr Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e20152982","DOI":"10.1542\/peds.2015-2982","article-title":"Recurrent urinary tract infections in children with bladder and bowel dysfunction.","volume":"137","author":"Shaikh","year":"2016","journal-title":"Pediatrics."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00467-020-04654-9","article-title":"Urine neutrophil gelatinase-associated lipocalin in girls with recurrent urinary tract infections.","volume":"35","author":"Forster","year":"2020","journal-title":"Pediatr Nephrol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.juro.2009.01.010","article-title":"Increased urinary neutrophil gelatinase associated lipocalin levels in a rat model of upper urinary tract infection.","volume":"181","author":"Ichino","year":"2009","journal-title":"J Urol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00467-015-3194-3","article-title":"Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.","volume":"31","author":"Parmaks\u0131z","year":"2016","journal-title":"Pediatr Nephrol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1756287220974133","DOI":"10.1177\/1756287220974133","article-title":"Increased urinary markers of kidney damage in the institutionalized frail elderly due to recurrent urinary tract infections.","volume":"12","author":"Lorenzo-G\u00f3mez","year":"2020","journal-title":"Ther Adv Urol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00467-020-04863-2","article-title":"Reduced urinary excretion of neutrophil gelatinase-associated lipocalin as a risk factor for recurrence of febrile urinary tract infection in children.","volume":"36","author":"Yamanouchi","year":"2021","journal-title":"Pediatr Nephrol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2215\/CJN.00980110","article-title":"The origin of multiple molecular forms in urine of HNL\/NGAL.","volume":"5","author":"Cai","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1128\/iai.65.8.3451-3456.1997","article-title":"Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration.","volume":"65","author":"Godaly","year":"1997","journal-title":"Infect Immun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI116650","article-title":"Interleukin-8 and the neutrophil response to mucosal gram-negative infection.","volume":"92","author":"Agace","year":"1993","journal-title":"J Clin Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.4049\/jimmunol.165.9.5287","article-title":"Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice.","volume":"165","author":"Godaly","year":"2000","journal-title":"J Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1084\/jem.192.6.881","article-title":"Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.","volume":"192","author":"Frend\u00e9us","year":"2000","journal-title":"J Exp Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1086\/512620","article-title":"Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection.","volume":"195","author":"Lundstedt","year":"2007","journal-title":"J Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1371\/journal.pone.0000825","article-title":"A genetic basis of susceptibility to acute pyelonephritis.","volume":"2","author":"Lundstedt","year":"2007","journal-title":"PLoS One."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1128\/CDLI.12.12.1358-1363.2005","article-title":"Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.","volume":"12","author":"Smithson","year":"2005","journal-title":"Clin Diagn Lab Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1744-313X.2012.01096.x","article-title":"Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children.","volume":"39","author":"Javor","year":"2012","journal-title":"Int J Immunogenet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/nep.13260","article-title":"Association between interleukin 8-receptor gene (CXCR1 and CXCR2) polymorphisms and urinary tract infection: evidence from 4097 subjects.","volume":"24","author":"Han","year":"2019","journal-title":"Nephrology (Carlton)."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1111\/j.1462-5822.2008.01230.x","article-title":"G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.","volume":"10","author":"Ingersoll","year":"2008","journal-title":"Cell Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1001042","DOI":"10.1371\/journal.ppat.1001042N","article-title":"Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.","volume":"6","author":"Hannan","year":"2010","journal-title":"PLoS Pathog."},{"key":"B71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ebiom.2014.10.011","article-title":"Inhibition of cyclooxygenase-2 prevents chronic and recurrent cystitis.","volume":"1","author":"Hannan","year":"2014","journal-title":"EBioMed."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e202000948","DOI":"10.26508\/lsa.202000948","article-title":"Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women.","volume":"4","author":"Ebrahimzadeh","year":"2021","journal-title":"Life Sci Alliance."},{"key":"B73","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0301-008200070-7","article-title":"Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder.","volume":"57","author":"Yoshimura","year":"1999","journal-title":"Prog Neurobiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jpain.2004.01.001","article-title":"Increased nerve growth factor expression triggers bladder overactivity.","volume":"5","author":"Lamb","year":"2004","journal-title":"J Pain."},{"key":"B75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5213\/inj.1630454.227","article-title":"Lower levels of urinary nerve growth factor might predict recurrent urinary tract infections in women.","volume":"20","author":"Chuang","year":"2016","journal-title":"Int Neurourol J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1464-410X.2010.09585.x","article-title":"Urinary nerve growth factor in women with overactive bladder syndrome.","volume":"107","author":"Liu","year":"2011","journal-title":"BJU Int."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1681\/ASN.2015060700","article-title":"Polymorphisms in \u03b1-defensin-encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux.","volume":"27","author":"Schwaderer","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/iai.27.2.657-666.1980","article-title":"Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae.","volume":"27","author":"Orskov","year":"1980","journal-title":"Infect Immun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1523-1755.2004.00452.x","article-title":"Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication.","volume":"65","author":"Bates","year":"2004","journal-title":"Kidney Int."},{"key":"B80","doi-asserted-by":"publisher","first-page":"F795","DOI":"10.1152\/ajprenal.00357.2003","article-title":"Ablation of the tamm-horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli.","volume":"286","author":"Mo","year":"2004","journal-title":"Am J Physiol Renal Physiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF00262110","article-title":"Excretion of urinary tamm-horsfall glycoprotein in girls with recurrent urinary tract infections.","volume":"15","author":"Lose","year":"1987","journal-title":"Urol Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/s0022-534739687-8","article-title":"Urinary excretion of tamm-horsfall protein in women with recurrent urinary tract infections.","volume":"144","author":"Reinhart","year":"1990","journal-title":"J Urol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000474754","article-title":"Quantitation of urinary tamm-horsfall protein in children with urinary tract infection.","volume":"22","author":"Reinhart","year":"1992","journal-title":"Eur Urol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"C316","DOI":"10.1152\/ajpcell.00195.2020","article-title":"Recent progress on surfactant protein A: cellular function in lung and kidney disease development.","volume":"319","author":"King","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1753425915609973","article-title":"Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.","volume":"22","author":"Hu","year":"2016","journal-title":"Innate Immun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1620\/tjem.221.35","article-title":"Polymorphisms in the surfactant protein a gene are associated with the susceptibility to recurrent urinary tract infection in Chinese women.","volume":"221","author":"Liu","year":"2010","journal-title":"Tohoku J Exp Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0020-729200480-5","article-title":"Bacterial adherence and immune response in recurrent urinary tract infection.","volume":"75","author":"Suman","year":"2001","journal-title":"Int J Gynaecol Obstet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.5980\/jpnjurol1928.70.10_1129","article-title":"[The study of urinary secretory IgA. (I) its localization in the urinary tract (author\u2019s transl)].","volume":"70","author":"Kuriyama","year":"1979","journal-title":"Nihon Hinyokika Gakkai Zasshi."},{"key":"B89","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1128\/iai.22.3.790-797.1978","article-title":"Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells.","volume":"22","author":"Svanborg-Ed\u00e9n","year":"1978","journal-title":"Infect Immun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/KI.1983.90","article-title":"Does low urinary sIgA predispose to urinary tract infection?","volume":"23","author":"Riedasch","year":"1983","journal-title":"Kidney Int."},{"key":"B91","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/s0022-347680110-x","article-title":"Urinary sIgA in children with urinary tract infection.","volume":"109","author":"Fliedner","year":"1986","journal-title":"J Pediatr."},{"key":"B92","first-page":"69","article-title":"Mucosal immunity in the urinary tract: changes in sIgA, FSC and total IgA with age and in urinary tract infection.","volume":"48","author":"James-Ellison","year":"1997","journal-title":"Clin Nephrol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000186100","article-title":"Urinary IgA, secretory IgA and secretory component in women with recurrent urinary tract infections.","volume":"56","author":"Floege","year":"1990","journal-title":"Nephron."},{"key":"B94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MNH.0b013e3282ff64a3","article-title":"Vitamin D and the immune system: role in potection against bacterial infection.","volume":"17","author":"Bikle","year":"2008","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1586\/eri.10.102","article-title":"Vitamin D: emerging roles in infection and immunity.","volume":"8","author":"Bartley","year":"2010","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nm1407","article-title":"The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.","volume":"12","author":"Chromek","year":"2006","journal-title":"Nat Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1128\/IAI.01393-13","article-title":"Role of urinary cathelicidin LL-37 and human \u03b2-defensin 1 in uncomplicated Escherichia coli urinary tract infections.","volume":"82","author":"Nielsen","year":"2014","journal-title":"Infect Immun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","article-title":"Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e15580","DOI":"10.1371\/journal.pone.0015580","article-title":"Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder.","volume":"5","author":"Hertting","year":"2010","journal-title":"PLoS One."},{"key":"B100","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4274\/jcrpe.2563","article-title":"The association between serum 25-hydroxy vitamin D level and urine cathelicidin in children with a urinary tract infection.","volume":"8","author":"\u00d6v\u00fcn\u00e7 Hac\u0131hamdio\u011flu","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000370046","article-title":"The association between vitamin D levels and urinary tract infection in children.","volume":"83","author":"Tekin","year":"2015","journal-title":"Horm Res Paediatr."},{"key":"B102","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5114\/aoms.2016.63262","article-title":"Vitamin D deficiency is associated with urinary tract infection in children.","volume":"14","author":"Shalaby","year":"2018","journal-title":"Arch Med Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.nmni.2021.100911","article-title":"The serum vitamin D levels in children with urinary tract infection: a case-control study.","volume":"43","author":"Sadeghzadeh","year":"2021","journal-title":"New Microbes New Infect."},{"key":"B104","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/20469047.2020.1771244","article-title":"Relationship between low serum vitamin D status and urinary tract infection in children: a case-control study.","volume":"40","author":"Mahmoudzadeh","year":"2020","journal-title":"Paediatr Int Child Health."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e4137","DOI":"10.1097\/MD.0000000000004137","article-title":"Low serum 25-hydroxyvitamin D level and risk of urinary tract infection in infants.","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"B106","first-page":"134","article-title":"Vitamin D and urinary tract infection: a systematic review and meta-analysis.","volume":"49","author":"Deng","year":"2019","journal-title":"Ann Clin Lab Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1016\/j.ijid.2013.06.007","article-title":"The association between serum levels of vitamin D and recurrent urinary tract infections in premenopausal women.","volume":"17","author":"Nseir","year":"2013","journal-title":"Int J Infect Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/apa.14499","article-title":"Association between vitamin D, antimicrobial peptides and urinary tract infection in infants and young children.","volume":"108","author":"Georgieva","year":"2019","journal-title":"Acta Paediatr."},{"key":"B109","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/children8050419","article-title":"Vitamin D status and its role in first-time and recurrent urinary tract infections in children: a case-control study.","volume":"8","author":"Muntean","year":"2021","journal-title":"Children (Basel)."},{"key":"B110","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00467-011-2000-0","article-title":"Vitamin D receptor gene polymorphism in children with urinary tract infection.","volume":"27","author":"Aslan","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41390-018-0092-y","article-title":"Vitamin D receptor gene (FokI, TaqI, BsmI, and ApaI) polymorphisms in children with urinary tract infection.","volume":"84","author":"Mahyar","year":"2018","journal-title":"Pediatr Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5662\/wjm.v5.i2.13","article-title":"Recurrent urinary tract infections in children: preventive interventions other than prophylactic antibiotics.","volume":"5","author":"Tewary","year":"2015","journal-title":"World J Methodol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/23744235.2016.1201853","article-title":"Prevention of urinary tract infections with vitamin D supplementation 20,000 IU per week for five years. Results from an RCT including 511 subjects.","volume":"48","author":"Jorde","year":"2016","journal-title":"Infect Dis (Lond)."},{"key":"B114","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/abr.abr_149_18","article-title":"Is vitamin D supplementation effective in prevention of recurrent urinary tract infections in the pediatrics? A randomized triple-masked controlled trial.","volume":"7","author":"Merrikhi","year":"2018","journal-title":"Adv Biomed Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.931717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:03:38Z","timestamp":1656911018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.931717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":114,"alternative-id":["10.3389\/fmed.2022.931717"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.931717","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"article-number":"931717"}}